ACO Name and Location

JFK Population Health Company, LLC
dba. JFK Health ACO
80 James Street
Edison, NJ 08820

ACO Primary Contact

Primary Contact Name Sheilah McCoy BSN, RN
Primary Contact Phone Number 732-744-5980
Primary Contact Email Address sheilah.mccoy@hmhn.org

Organizational Information

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Allison L Faches PA

N

Arvind Doshi MD PA

N

Bruce Soriano

N

Brunswick Internal Medicine Group, PC

N

Cardiovascular Consultants, PA

N

CGF Medical Center PA

N

Clarabarton Cardio Medical Association Inc.

N

Community Hospital Group Inc

N

Dewan S. Khan M.D., P.C.

N

Edison Nephrorlogy Consultants

N

Endocrinology T&S

N

Fauzia Hameed, MD, LLC

N

Forrayan  LLC

N

Harry Collins, MD LLC

N

Healthy Life MD, LLC

N

Indravadan T Patel MD PA

N

Iqbal Singh

N

Janardhan Bollu

N

Janardhan Bollu MD PA

N

Jasbir K.Kasuri MD PC

N

Jersey Heart Center LLC

N

JFK Medical Associates, PA

N

JFK Medical Group, PC

N

Joseph Robbins

N

Kespra Medical Center LLC

N

Ketankumar Vaidya, LLC

N

Kishore Ramchandani

N

Linden Medical Group, LLC

N

M.A. Sarraf, M.D., P.A.

N

Menlo Park Medical Group P.A.

N

Mid Jersey Medical Associates PA

N

Mohammad A. Zubair, LLC

N

Mohinder Singh

N

Nandini Moray, MD PA

N

Neha Shah MD LLC

N

Oak Tree Family Practice, LLC

N

Oak Tree Patient Care PC

N

Pradip A. Shah, M.D. P.C.

N

Primary Care Nj Llc

N

Pulmnary Internists, PA

N

Ricardo Calvo

N

Richard Menashe

N

Shefali Patel

N

Sunil Patel

N

Syed Siddiq

N

Thomas J. Cassidy MD LLC

N

ACO governing body:

Member

Member's Voting Power – Expressed as a percentage or number

Membership Type

ACO Participant Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Sharma

Bhudev

Chair

1

ACO Participant Representative

JFK Medical Associates

Flores

Maria

MD

1

ACO Participant Representative

JFK Medical Associates

Patel

Rajesh

DO

1

ACO Participant Representative

Forrayan

Vaidya

Ketankumar

MD

1

ACO Participant Representative

Ketan Vaidya, MD, LLC

Oser

William

ACO Executive Director

0

Other

 

Rossy

William

MD

1

ACO Participant Representative

JFK Medical Associates

Soriano

Bruce

MD

1

ACO Participant Representative

Bruce V. Soriano, MD

Spirn

Franklin

MD

0

Medicare Beneficiary Representative

 

Thornton

Amie

CHE

1

Other

Community Hospital Group, Inc

Hand

Richard

CFO

0

Other

 

McCoy

Sheilah

Director of Care Coordination

0

Other

 

Key ACO Clinical and Administrative Leadership:

ACO Executive: William F. Oser, MD
Medical Director: Robin O. Winter, MD
Compliance Officeer: Donna Gioia
Quality Assurance/improvement Officer: Robert Bayly, MD

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
ACO Quality Committee Dr. Bhudev Sharma, MD   Chairman
ACO Finance Committee Mr. Richard Handy CFO   Chairman

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2020, $2,377,082.09

  • Second Agreement Period
    • Performance Year 2019, $3,661,811.05
    • Performance Year 2018, $4,233,662.16
    • Performance Year 2017, $0
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure:  50%
      • Proportion invested in redesigned care processes/resources: 0
      • Proportion of distribution to ACO participants:  50%
        • ACO Participant Providers: 85%
        • ACO Participant Hospital: 15%

  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure:  50%
      • Proportion invested in redesigned care processes/resources: 0
      • Proportion of distribution to ACO participants:
        • ACO Participant Providers: 85%
        • ACO Participant Hospital: 15%
    • Performance Year 2018
      • Proportion invested in infrastructure: 26%
      • Proportion invested in redesigned care processes/resources: 0
      • Proportion of distribution to ACO participants:
        • ACO Participant Providers: 85%
        • ACO Participant Hospital: 15%
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/A

Quality Performance Results:

AO Quality Measure Number

Measure Name

Your ACO Performance Rate*

Current Year Mean Performance Rate (SSP ACOs)

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)

0.90

0.95

ACO-13

Falls: Screening for Future Fall Risk

74.86

84.97

ACO-14

Preventive Care and Screening: Influenza Immunization

71.49

76.03

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

93.33

81.67

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

44.61

71.46

ACO-19

Colorectal Cancer Screening

62.28

72.59

ACO-20

ACO-20 Breast Cancer Screening

75.88

73.79

ACO-34

CAHPS: Stewardship of Patient Resources [1]

62.56

74.05

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

89.49

83.37

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

12.68

14.70

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

80.68

72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

Note: For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.